Jackson Grant Investment Advisers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8K Hold
16
﹤0.01% 375
2026
Q1
$3.38K Hold
16
﹤0.01% 366
2025
Q4
$3.29K Hold
16
﹤0.01% 369
2025
Q3
$2.51K Hold
16
﹤0.01% 388
2025
Q2
$2.69K Hold
16
﹤0.01% 354
2025
Q1
$2.2K Hold
16
﹤0.01% 356
2024
Q4
$1.89K Hold
16
﹤0.01% 377
2024
Q3
$1.77K Hold
16
﹤0.01% 380
2024
Q2
$1.57K Hold
16
﹤0.01% 377
2024
Q1
$1.79K Hold
16
﹤0.01% 365
2023
Q4
$1.61K Hold
16
﹤0.01% 363
2023
Q3
$1.39K Hold
16
﹤0.01% 370
2023
Q2
$1.51K Hold
16
﹤0.01% 388
2023
Q1
$1.21K Buy
+16
New +$1.21K ﹤0.01% 434

Other funds holding CAH

Jackson Grant Investment Advisers's CAH Position: Q2 2026 in Review

Jackson Grant Investment Advisers held its Cardinal Health (CAH) position steady in Q2 2026 at 16 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #375.

Jackson Grant Investment Advisers first reported a position in CAH in Q1 2023 and has held it in 14 quarters since. 617 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Jackson Grant Investment Advisers held 16 shares of Cardinal Health worth $3.8K as of Q2 2026.
  • Jackson Grant Investment Advisers left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up ﹤0.01% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #375 holding.
  • Jackson Grant Investment Advisers first reported a position in Cardinal Health in Q1 2023 and has held it in 14 quarters since.
  • 617 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.